PD-166285 hydrate

• 产品号: PZ0116
• 分子式: C26H31Cl4N5O3
• 分子量: 603.36804
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: PD-166285 hydrate
• IUPAC标准名: 6-(2,6-dichlorophenyl)-2-({4-[2-(diethylamino)ethoxy]phenyl}amino)-8-methyl-7H,8H-pyrido[2,3-d]pyrimidin-7-one hydrate dihydrochloride
• IUPAC传统名: 6-(2,6-dichlorophenyl)-2-({4-[2-(diethylamino)ethoxy]phenyl}amino)-8-methylpyrido[2,3-d]pyrimidin-7-one hydrate dihydrochloride
• 别名: 6-(2,6-Dichlorophenyl)-2-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-8-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one dihydrochloride hydrate

产品登记号

• MDL号: MFCD17215957

产品性质

• Empirical Formula (Hill Notation): C26H27Cl2N5O2·2HCl
• 纯度: ≥98% (HPLC)
• 外观: yellow powder
• 溶解度: DMSO: ≥20 mg/mL
• 溶解度: H2O: ≥5 mg/mL
• GHS警示词: Danger
• GHS危险声明: H301-H413
• 欧盟危险性物质标志: 有毒(Toxic) (T)
• GHS警示性声明: P301 + P310
• RID/ADR: UN 2811 6.1/PG 3
• 危险公开号: 25
• 安全公开号: 45
• 保存温度: room temp
• 联合国危险货物等级: 6.1
• 联合国危险货物编号: 2811
• 联合国危险货物包装类别(PG): 3
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
PD-166285 hydrate is a broad spectrum protein tyrosine kinase inhibitor; Src and FGFR kinase inhibitor.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.

详细说明 (简体中文)

Biochem/physiol Actions
PD-166285 hydrate is a broad spectrum protein tyrosine kinase inhibitor; Src and FGFR kinase inhibitor.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.